Pentraxin-3 regulates the inflammatory activity of macrophages

Aya Shiraki1, Norihiko Kotooka1, Hiroshi Komoda1

  • 1Department of Cardiovascular Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, Japan.

Abstract

Insights

Pentraxin-3 (PTX3) regulates macrophage activity by reducing inflammatory cytokines like IL-1β and TNF-α. This suggests PTX3 plays a key role in resolving inflammation and offers therapeutic potential.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • Pentraxin-3 (PTX3) is implicated in cardiovascular diseases and vascular inflammation.
  • The precise functions of PTX3 in inflammatory processes, particularly within macrophages, remain incompletely understood.

Purpose of the Study:

  • To elucidate the functional role of Pentraxin-3 (PTX3) in modulating macrophage inflammatory responses.
  • To investigate PTX3's impact on cytokine production, signaling pathways, and phagocytic activity in macrophages.

Main Methods:

  • Recombinant PTX3 was applied to THP-1 macrophages and primary human macrophages.
  • Cytokine and chemokine levels (IL-1β, TNF-α, MCP-1) were quantified.
  • PTX3-silenced apoptotic macrophages were utilized to assess phagocytosis and surface marker expression (HLA-DR, CD86).

Main Results:

  • PTX3 significantly reduced macrophage-derived IL-1β, TNF-α, and MCP-1 levels, while inducing TGF-β activation.
  • PTX3 inhibited NF-κB activation and promoted Akt phosphorylation.
  • Silencing PTX3 in apoptotic macrophages enhanced binding and increased HLA-DR and CD86 expression, alongside IL-1β production.

Conclusions:

  • Pentraxin-3 (PTX3) functions as a novel regulator of macrophage activity.
  • PTX3's anti-inflammatory effects suggest a crucial role in inflammation resolution.